BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9785493)

  • 1. Serological and virological responses in mules and donkeys following inoculation with African horse sickness virus serotype 4.
    el Hasnaoui H; el Harrak M; Zientara S; Laviada M; Hamblin C
    Arch Virol Suppl; 1998; 14():29-36. PubMed ID: 9785493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, virological and immune responses of normal and immunosuppressed donkeys (Equus asinus africanus) after inoculation with African horse sickness virus.
    Fassi-Fihri O; el Harrak M; Fassi-Fehri MM
    Arch Virol Suppl; 1998; 14():49-56. PubMed ID: 9785495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of reverse transcriptase-polymerase chain reaction (RT-PCR) and dot-blot hybridisation for the detection and identification of African horse sickness virus nucleic acids.
    Zientara S; Sailleau C; Moulay S; Crucière C; el-Harrak M; Laegreid WW; Hamblin C
    Arch Virol Suppl; 1998; 14():317-27. PubMed ID: 9785517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donkeys as reservoirs of African horse sickness virus.
    Hamblin C; Salt JS; Mellor PS; Graham SD; Smith PR; Wohlsein P
    Arch Virol Suppl; 1998; 14():37-47. PubMed ID: 9785494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness.
    Hamblin C; Mellor PS; Graham SD; Hooghuis H; Montejano RC; Cubillo MA; Boned J
    Epidemiol Infect; 1991 Apr; 106(2):365-71. PubMed ID: 1902185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of an indirect fluorescent antibody assay for the detection of African horse sickness virus antibodies.
    el Hasnaoui H; el Harrak M; Tber A; Fikri A; Laghzaoui K; Bikour MH
    Arch Virol Suppl; 1998; 14():305-10. PubMed ID: 9785515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48h before, or 48h after challenge.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Antiviral Res; 2015 Apr; 116():27-33. PubMed ID: 25643968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
    Calvo-Pinilla E; de la Poza F; Gubbins S; Mertens PP; Ortego J; Castillo-Olivares J
    Virus Res; 2014 Feb; 180():23-30. PubMed ID: 24333835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.
    Oura CA; Ivens PA; Bachanek-Bankowska K; Bin-Tarif A; Jallow DB; Sailleau C; Maan S; Mertens PC; Batten CA
    Epidemiol Infect; 2012 Mar; 140(3):462-5. PubMed ID: 21733265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of African horse sickness virus infection of Equus zebra hartmannae in the south-western Khomas Region, Namibia.
    Becker E; Venter GJ; Greyling T; Molini U; van Hamburg H
    Transbound Emerg Dis; 2018 Feb; 65(1):278-280. PubMed ID: 28406577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses.
    Bougrine SI; Fihri OF; Fehri MM
    Arch Virol Suppl; 1998; 14():329-36. PubMed ID: 9785518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The detection of African horse sickness virus antigens and antibodies in young Equidae.
    Hamblin C; Anderson EC; Mellor PS; Graham SD; Mertens PP; Burroughs JN
    Epidemiol Infect; 1992 Feb; 108(1):193-201. PubMed ID: 1547837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sero-prevalence and sero-incidence of African horse sickness and equine encephalosis in selected horse and donkey populations in Zimbabwe.
    Gordon SJG; Bolwell C; Rogers CW; Musuka G; Kelly P; Guthrie A; Mellor PS; Hamblin C
    Onderstepoort J Vet Res; 2017 May; 84(1):e1-e5. PubMed ID: 28582979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.